A new five-year long international study to assess the efficiency of statins or ACE inhibitors amongst adolescents with type 1 diabetes may determine whether these drugs lower the risk of developing diabetes complications .
Diabetes UK, the British Heart Foundation and the Juvenile Diabetes Research Foundation will fund the study. Diabetes complications are unfortunately common amongst people with type 1 diabetes, but both statins and ACE inhibitors could lower complications risks.
A team of experts at Cambridge University will coordinate the Adolescent Type 1 Diabetes Intervention Trial. Professor Dunger, of the university, reportedly commented: “Diabetes significantly increases the risk of heart disease and is the leading cause of endstage kidney failure. By working with high-risk adolescents, this study will help us to find out whether statins and ACE inhibitors can prevent these devastating complications at the earliest stage.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…